Optimizing Dosing of Trastuzumab Deruxtecan in HER2 -Mutant Non–Small-Cell Lung Cancer: A Reminder That More Is Not Always Better
Journal of Clinical Oncology · 2023
DOI: 10.1200/jco.23.01768 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Clinical Oncology, 2023. Verfasst von Hui Jing Hoe und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Immunoconjugates. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
and toxicity for patients with previously treated HER2 mutation-positive NSCLC.Ongoing studies are evaluating T-DXd 5.4 mg/kg once every 3 weeks compared with chemotherapy plus pembrolizumab in the first-line setting for HER2-mutant NSCLC (DESTINY-Lung04) and in combination strategies with immunotherapy and chemotherapy.In these settings, dose optimization and mitigation of toxicities including drug-induced ILD/pneumonitis and other cumulative low-grade toxicities that are impactful for patients will be essential to enable long-term delivery of this effective new class of therapeutics and maximize therapeutic outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
ORCID-Profile: Hui Jing Hoe, Benjamin J Solomon
Zitieren
APA
Hoe, H. J., & Solomon, B. J. (2023). Optimizing Dosing of Trastuzumab Deruxtecan in HER2 -Mutant Non–Small-Cell Lung Cancer: A Reminder That More Is Not Always Better. Journal of Clinical Oncology. https://doi.org/10.1200/jco.23.01768
Vancouver
Hoe HJ, Solomon BJ. Optimizing Dosing of Trastuzumab Deruxtecan in HER2 -Mutant Non–Small-Cell Lung Cancer: A Reminder That More Is Not Always Better. Journal of Clinical Oncology. 2023. doi:10.1200/jco.23.01768
BibTeX
@article{Hoe2023,
author = {Hoe, Hui Jing and Solomon, Benjamin J},
title = {Optimizing Dosing of Trastuzumab Deruxtecan in HER2 -Mutant Non–Small-Cell Lung Cancer: A Reminder That More Is Not Always Better},
journal = {Journal of Clinical Oncology},
year = {2023},
doi = {10.1200/jco.23.01768}
}
EUVIMED